nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefepime—Consciousness abnormal—Vincristine—colon cancer	0.0487	0.0487	CcSEcCtD
Cefepime—Ca++ increased—Capecitabine—colon cancer	0.0439	0.0439	CcSEcCtD
Cefepime—Calcium low—Capecitabine—colon cancer	0.0407	0.0407	CcSEcCtD
Cefepime—Blood calcium decreased—Capecitabine—colon cancer	0.0243	0.0243	CcSEcCtD
Cefepime—Neurotoxicity—Vincristine—colon cancer	0.0218	0.0218	CcSEcCtD
Cefepime—Altered state of consciousness—Vincristine—colon cancer	0.0183	0.0183	CcSEcCtD
Cefepime—Septicemia—Methotrexate—colon cancer	0.0181	0.0181	CcSEcCtD
Cefepime—Local reaction—Fluorouracil—colon cancer	0.0142	0.0142	CcSEcCtD
Cefepime—Neurotoxicity—Capecitabine—colon cancer	0.0142	0.0142	CcSEcCtD
Cefepime—Myoclonus—Vincristine—colon cancer	0.014	0.014	CcSEcCtD
Cefepime—Prothrombin level increased—Capecitabine—colon cancer	0.0134	0.0134	CcSEcCtD
Cefepime—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.0134	0.0134	CcSEcCtD
Cefepime—Pruritus genital—Capecitabine—colon cancer	0.0132	0.0132	CcSEcCtD
Cefepime—Encephalopathy—Fluorouracil—colon cancer	0.0123	0.0123	CcSEcCtD
Cefepime—Altered state of consciousness—Capecitabine—colon cancer	0.0119	0.0119	CcSEcCtD
Cefepime—Neurotoxicity—Methotrexate—colon cancer	0.0106	0.0106	CcSEcCtD
Cefepime—Extravasation—Vincristine—colon cancer	0.00968	0.00968	CcSEcCtD
Cefepime—Extravasation—Irinotecan—colon cancer	0.00943	0.00943	CcSEcCtD
Cefepime—Vasodilation procedure—Irinotecan—colon cancer	0.00936	0.00936	CcSEcCtD
Cefepime—Vasodilation—Irinotecan—colon cancer	0.00936	0.00936	CcSEcCtD
Cefepime—Myoclonus—Capecitabine—colon cancer	0.00915	0.00915	CcSEcCtD
Cefepime—Extravasation—Fluorouracil—colon cancer	0.00903	0.00903	CcSEcCtD
Cefepime—Oral candidiasis—Capecitabine—colon cancer	0.00867	0.00867	CcSEcCtD
Cefepime—Encephalopathy—Capecitabine—colon cancer	0.00858	0.00858	CcSEcCtD
Cefepime—Phosphatase alkaline increased—Irinotecan—colon cancer	0.00823	0.00823	CcSEcCtD
Cefepime—Inflammation—Fluorouracil—colon cancer	0.00812	0.00812	CcSEcCtD
Cefepime—Hypercalcaemia—Capecitabine—colon cancer	0.00792	0.00792	CcSEcCtD
Cefepime—Colitis—Irinotecan—colon cancer	0.0079	0.0079	CcSEcCtD
Cefepime—Coma—Vincristine—colon cancer	0.00772	0.00772	CcSEcCtD
Cefepime—Coma—Fluorouracil—colon cancer	0.0072	0.0072	CcSEcCtD
Cefepime—Sepsis—Irinotecan—colon cancer	0.00714	0.00714	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Irinotecan—colon cancer	0.00687	0.00687	CcSEcCtD
Cefepime—Sepsis—Fluorouracil—colon cancer	0.00684	0.00684	CcSEcCtD
Cefepime—Hepatic failure—Vincristine—colon cancer	0.00682	0.00682	CcSEcCtD
Cefepime—Encephalopathy—Methotrexate—colon cancer	0.00638	0.00638	CcSEcCtD
Cefepime—Renal impairment—Irinotecan—colon cancer	0.00627	0.00627	CcSEcCtD
Cefepime—Hypocalcaemia—Capecitabine—colon cancer	0.00601	0.00601	CcSEcCtD
Cefepime—Liver disorder—Methotrexate—colon cancer	0.00601	0.00601	CcSEcCtD
Cefepime—Inflammation—Capecitabine—colon cancer	0.00568	0.00568	CcSEcCtD
Cefepime—Phosphatase alkaline increased—Capecitabine—colon cancer	0.00551	0.00551	CcSEcCtD
Cefepime—Stupor—Methotrexate—colon cancer	0.00549	0.00549	CcSEcCtD
Cefepime—Depressed level of consciousness—Capecitabine—colon cancer	0.00532	0.00532	CcSEcCtD
Cefepime—Colitis—Capecitabine—colon cancer	0.00529	0.00529	CcSEcCtD
Cefepime—Candida infection—Capecitabine—colon cancer	0.00526	0.00526	CcSEcCtD
Cefepime—Pancytopenia—Vincristine—colon cancer	0.00503	0.00503	CcSEcCtD
Cefepime—Neutropenia—Vincristine—colon cancer	0.00496	0.00496	CcSEcCtD
Cefepime—Eosinophilia—Fluorouracil—colon cancer	0.00489	0.00489	CcSEcCtD
Cefepime—Neutropenia—Irinotecan—colon cancer	0.00483	0.00483	CcSEcCtD
Cefepime—Sepsis—Capecitabine—colon cancer	0.00478	0.00478	CcSEcCtD
Cefepime—Pneumonia—Vincristine—colon cancer	0.00475	0.00475	CcSEcCtD
Cefepime—Extravasation—Methotrexate—colon cancer	0.0047	0.0047	CcSEcCtD
Cefepime—Pancytopenia—Fluorouracil—colon cancer	0.00469	0.00469	CcSEcCtD
Cefepime—Phlebitis—Capecitabine—colon cancer	0.00464	0.00464	CcSEcCtD
Cefepime—Pneumonia—Irinotecan—colon cancer	0.00463	0.00463	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.00459	0.00459	CcSEcCtD
Cefepime—Hepatic function abnormal—Capecitabine—colon cancer	0.00457	0.00457	CcSEcCtD
Cefepime—Renal failure—Irinotecan—colon cancer	0.00452	0.00452	CcSEcCtD
Cefepime—Hepatic failure—Capecitabine—colon cancer	0.00445	0.00445	CcSEcCtD
Cefepime—Pneumonia—Fluorouracil—colon cancer	0.00443	0.00443	CcSEcCtD
Cefepime—Haemolytic anaemia—Capecitabine—colon cancer	0.00443	0.00443	CcSEcCtD
Cefepime—Urinary tract infection—Fluorouracil—colon cancer	0.00428	0.00428	CcSEcCtD
Cefepime—Inflammation—Methotrexate—colon cancer	0.00423	0.00423	CcSEcCtD
Cefepime—Hallucination—Vincristine—colon cancer	0.00422	0.00422	CcSEcCtD
Cefepime—Renal impairment—Capecitabine—colon cancer	0.0042	0.0042	CcSEcCtD
Cefepime—Haemoglobin—Irinotecan—colon cancer	0.00415	0.00415	CcSEcCtD
Cefepime—Haemorrhage—Irinotecan—colon cancer	0.00413	0.00413	CcSEcCtD
Cefepime—Agranulocytosis—Fluorouracil—colon cancer	0.00411	0.00411	CcSEcCtD
Cefepime—Vaginal inflammation—Methotrexate—colon cancer	0.0041	0.0041	CcSEcCtD
Cefepime—Haemoglobin—Fluorouracil—colon cancer	0.00398	0.00398	CcSEcCtD
Cefepime—Depressed level of consciousness—Methotrexate—colon cancer	0.00396	0.00396	CcSEcCtD
Cefepime—Haemorrhage—Fluorouracil—colon cancer	0.00396	0.00396	CcSEcCtD
Cefepime—Vaginal infection—Methotrexate—colon cancer	0.00387	0.00387	CcSEcCtD
Cefepime—Aplastic anaemia—Methotrexate—colon cancer	0.00385	0.00385	CcSEcCtD
Cefepime—Coma—Methotrexate—colon cancer	0.00375	0.00375	CcSEcCtD
Cefepime—Chills—Irinotecan—colon cancer	0.00371	0.00371	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.0036	0.0036	CcSEcCtD
Cefepime—Sepsis—Methotrexate—colon cancer	0.00356	0.00356	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00352	0.00352	CcSEcCtD
Cefepime—Erythema—Fluorouracil—colon cancer	0.00344	0.00344	CcSEcCtD
Cefepime—Anaemia—Vincristine—colon cancer	0.00341	0.00341	CcSEcCtD
Cefepime—Agitation—Vincristine—colon cancer	0.00339	0.00339	CcSEcCtD
Cefepime—Anaemia—Irinotecan—colon cancer	0.00332	0.00332	CcSEcCtD
Cefepime—Bronchitis—Capecitabine—colon cancer	0.00332	0.00332	CcSEcCtD
Cefepime—Hepatic failure—Methotrexate—colon cancer	0.00331	0.00331	CcSEcCtD
Cefepime—Leukopenia—Vincristine—colon cancer	0.00331	0.00331	CcSEcCtD
Cefepime—Pancytopenia—Capecitabine—colon cancer	0.00328	0.00328	CcSEcCtD
Cefepime—Neutropenia—Capecitabine—colon cancer	0.00323	0.00323	CcSEcCtD
Cefepime—Leukopenia—Irinotecan—colon cancer	0.00322	0.00322	CcSEcCtD
Cefepime—Convulsion—Vincristine—colon cancer	0.0032	0.0032	CcSEcCtD
Cefepime—Anaemia—Fluorouracil—colon cancer	0.00318	0.00318	CcSEcCtD
Cefepime—Pneumonia—Capecitabine—colon cancer	0.0031	0.0031	CcSEcCtD
Cefepime—Leukopenia—Fluorouracil—colon cancer	0.00308	0.00308	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00305	0.00305	CcSEcCtD
Cefepime—Renal failure—Capecitabine—colon cancer	0.00303	0.00303	CcSEcCtD
Cefepime—Anaphylactic shock—Vincristine—colon cancer	0.00301	0.00301	CcSEcCtD
Cefepime—Infection—Vincristine—colon cancer	0.00299	0.00299	CcSEcCtD
Cefepime—Urinary tract infection—Capecitabine—colon cancer	0.00299	0.00299	CcSEcCtD
Cefepime—Convulsion—Fluorouracil—colon cancer	0.00298	0.00298	CcSEcCtD
Cefepime—Confusional state—Irinotecan—colon cancer	0.00296	0.00296	CcSEcCtD
Cefepime—Thrombocytopenia—Vincristine—colon cancer	0.00295	0.00295	CcSEcCtD
Cefepime—Anaphylactic shock—Irinotecan—colon cancer	0.00293	0.00293	CcSEcCtD
Cefepime—Infection—Irinotecan—colon cancer	0.00292	0.00292	CcSEcCtD
Cefepime—Shock—Irinotecan—colon cancer	0.00289	0.00289	CcSEcCtD
Cefepime—Agranulocytosis—Capecitabine—colon cancer	0.00287	0.00287	CcSEcCtD
Cefepime—Thrombocytopenia—Irinotecan—colon cancer	0.00287	0.00287	CcSEcCtD
Cefepime—Confusional state—Fluorouracil—colon cancer	0.00283	0.00283	CcSEcCtD
Cefepime—Anaphylactic shock—Fluorouracil—colon cancer	0.00281	0.00281	CcSEcCtD
Cefepime—Infection—Fluorouracil—colon cancer	0.00279	0.00279	CcSEcCtD
Cefepime—Haemoglobin—Capecitabine—colon cancer	0.00278	0.00278	CcSEcCtD
Cefepime—Haemorrhage—Capecitabine—colon cancer	0.00276	0.00276	CcSEcCtD
Cefepime—Thrombocytopenia—Fluorouracil—colon cancer	0.00275	0.00275	CcSEcCtD
Cefepime—Paraesthesia—Vincristine—colon cancer	0.00271	0.00271	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00268	0.00268	CcSEcCtD
Cefepime—Paraesthesia—Irinotecan—colon cancer	0.00264	0.00264	CcSEcCtD
Cefepime—Dyspnoea—Irinotecan—colon cancer	0.00262	0.00262	CcSEcCtD
Cefepime—Erythema multiforme—Capecitabine—colon cancer	0.00261	0.00261	CcSEcCtD
Cefepime—Gastrointestinal disorder—Vincristine—colon cancer	0.0026	0.0026	CcSEcCtD
Cefepime—Pain—Vincristine—colon cancer	0.00258	0.00258	CcSEcCtD
Cefepime—Constipation—Vincristine—colon cancer	0.00258	0.00258	CcSEcCtD
Cefepime—Eosinophilia—Methotrexate—colon cancer	0.00255	0.00255	CcSEcCtD
Cefepime—Gastrointestinal disorder—Irinotecan—colon cancer	0.00253	0.00253	CcSEcCtD
Cefepime—Paraesthesia—Fluorouracil—colon cancer	0.00252	0.00252	CcSEcCtD
Cefepime—Pain—Irinotecan—colon cancer	0.00251	0.00251	CcSEcCtD
Cefepime—Constipation—Irinotecan—colon cancer	0.00251	0.00251	CcSEcCtD
Cefepime—Dyspnoea—Fluorouracil—colon cancer	0.00251	0.00251	CcSEcCtD
Cefepime—Chills—Capecitabine—colon cancer	0.00248	0.00248	CcSEcCtD
Cefepime—Gastrointestinal pain—Vincristine—colon cancer	0.00246	0.00246	CcSEcCtD
Cefepime—Pancytopenia—Methotrexate—colon cancer	0.00244	0.00244	CcSEcCtD
Cefepime—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00243	0.00243	CcSEcCtD
Cefepime—Feeling abnormal—Irinotecan—colon cancer	0.00242	0.00242	CcSEcCtD
Cefepime—Erythema—Capecitabine—colon cancer	0.00241	0.00241	CcSEcCtD
Cefepime—Neutropenia—Methotrexate—colon cancer	0.0024	0.0024	CcSEcCtD
Cefepime—Pain—Fluorouracil—colon cancer	0.0024	0.0024	CcSEcCtD
Cefepime—Gastrointestinal pain—Irinotecan—colon cancer	0.0024	0.0024	CcSEcCtD
Cefepime—Abdominal pain—Vincristine—colon cancer	0.00238	0.00238	CcSEcCtD
Cefepime—Body temperature increased—Vincristine—colon cancer	0.00238	0.00238	CcSEcCtD
Cefepime—Dysgeusia—Capecitabine—colon cancer	0.00236	0.00236	CcSEcCtD
Cefepime—Abdominal pain—Irinotecan—colon cancer	0.00232	0.00232	CcSEcCtD
Cefepime—Body temperature increased—Irinotecan—colon cancer	0.00232	0.00232	CcSEcCtD
Cefepime—Feeling abnormal—Fluorouracil—colon cancer	0.00232	0.00232	CcSEcCtD
Cefepime—Pneumonia—Methotrexate—colon cancer	0.00231	0.00231	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00227	0.00227	CcSEcCtD
Cefepime—Renal failure—Methotrexate—colon cancer	0.00225	0.00225	CcSEcCtD
Cefepime—Urticaria—Fluorouracil—colon cancer	0.00223	0.00223	CcSEcCtD
Cefepime—Anaemia—Capecitabine—colon cancer	0.00222	0.00222	CcSEcCtD
Cefepime—Body temperature increased—Fluorouracil—colon cancer	0.00222	0.00222	CcSEcCtD
Cefepime—Hypersensitivity—Vincristine—colon cancer	0.00222	0.00222	CcSEcCtD
Cefepime—Hypersensitivity—Irinotecan—colon cancer	0.00216	0.00216	CcSEcCtD
Cefepime—Leukopenia—Capecitabine—colon cancer	0.00215	0.00215	CcSEcCtD
Cefepime—Agranulocytosis—Methotrexate—colon cancer	0.00214	0.00214	CcSEcCtD
Cefepime—Hypersensitivity—Fluorouracil—colon cancer	0.00207	0.00207	CcSEcCtD
Cefepime—Haemoglobin—Methotrexate—colon cancer	0.00207	0.00207	CcSEcCtD
Cefepime—Diarrhoea—Vincristine—colon cancer	0.00206	0.00206	CcSEcCtD
Cefepime—Haemorrhage—Methotrexate—colon cancer	0.00206	0.00206	CcSEcCtD
Cefepime—Diarrhoea—Irinotecan—colon cancer	0.00201	0.00201	CcSEcCtD
Cefepime—Dizziness—Vincristine—colon cancer	0.00199	0.00199	CcSEcCtD
Cefepime—Pruritus—Fluorouracil—colon cancer	0.00199	0.00199	CcSEcCtD
Cefepime—Confusional state—Capecitabine—colon cancer	0.00198	0.00198	CcSEcCtD
Cefepime—Infection—Capecitabine—colon cancer	0.00195	0.00195	CcSEcCtD
Cefepime—Erythema multiforme—Methotrexate—colon cancer	0.00195	0.00195	CcSEcCtD
Cefepime—Dizziness—Irinotecan—colon cancer	0.00194	0.00194	CcSEcCtD
Cefepime—Shock—Capecitabine—colon cancer	0.00193	0.00193	CcSEcCtD
Cefepime—Diarrhoea—Fluorouracil—colon cancer	0.00192	0.00192	CcSEcCtD
Cefepime—Thrombocytopenia—Capecitabine—colon cancer	0.00192	0.00192	CcSEcCtD
Cefepime—Vomiting—Vincristine—colon cancer	0.00192	0.00192	CcSEcCtD
Cefepime—Rash—Vincristine—colon cancer	0.0019	0.0019	CcSEcCtD
Cefepime—Dermatitis—Vincristine—colon cancer	0.0019	0.0019	CcSEcCtD
Cefepime—Headache—Vincristine—colon cancer	0.00189	0.00189	CcSEcCtD
Cefepime—Vomiting—Irinotecan—colon cancer	0.00187	0.00187	CcSEcCtD
Cefepime—Dizziness—Fluorouracil—colon cancer	0.00186	0.00186	CcSEcCtD
Cefepime—Rash—Irinotecan—colon cancer	0.00185	0.00185	CcSEcCtD
Cefepime—Dermatitis—Irinotecan—colon cancer	0.00185	0.00185	CcSEcCtD
Cefepime—Chills—Methotrexate—colon cancer	0.00185	0.00185	CcSEcCtD
Cefepime—Headache—Irinotecan—colon cancer	0.00184	0.00184	CcSEcCtD
Cefepime—Erythema—Methotrexate—colon cancer	0.00179	0.00179	CcSEcCtD
Cefepime—Nausea—Vincristine—colon cancer	0.00179	0.00179	CcSEcCtD
Cefepime—Vomiting—Fluorouracil—colon cancer	0.00179	0.00179	CcSEcCtD
Cefepime—Rash—Fluorouracil—colon cancer	0.00177	0.00177	CcSEcCtD
Cefepime—Dermatitis—Fluorouracil—colon cancer	0.00177	0.00177	CcSEcCtD
Cefepime—Paraesthesia—Capecitabine—colon cancer	0.00176	0.00176	CcSEcCtD
Cefepime—Headache—Fluorouracil—colon cancer	0.00176	0.00176	CcSEcCtD
Cefepime—Dysgeusia—Methotrexate—colon cancer	0.00175	0.00175	CcSEcCtD
Cefepime—Dyspnoea—Capecitabine—colon cancer	0.00175	0.00175	CcSEcCtD
Cefepime—Nausea—Irinotecan—colon cancer	0.00174	0.00174	CcSEcCtD
Cefepime—Gastrointestinal disorder—Capecitabine—colon cancer	0.0017	0.0017	CcSEcCtD
Cefepime—Constipation—Capecitabine—colon cancer	0.00168	0.00168	CcSEcCtD
Cefepime—Pain—Capecitabine—colon cancer	0.00168	0.00168	CcSEcCtD
Cefepime—Nausea—Fluorouracil—colon cancer	0.00167	0.00167	CcSEcCtD
Cefepime—Anaemia—Methotrexate—colon cancer	0.00166	0.00166	CcSEcCtD
Cefepime—Feeling abnormal—Capecitabine—colon cancer	0.00162	0.00162	CcSEcCtD
Cefepime—Gastrointestinal pain—Capecitabine—colon cancer	0.00161	0.00161	CcSEcCtD
Cefepime—Leukopenia—Methotrexate—colon cancer	0.0016	0.0016	CcSEcCtD
Cefepime—Urticaria—Capecitabine—colon cancer	0.00156	0.00156	CcSEcCtD
Cefepime—Abdominal pain—Capecitabine—colon cancer	0.00155	0.00155	CcSEcCtD
Cefepime—Body temperature increased—Capecitabine—colon cancer	0.00155	0.00155	CcSEcCtD
Cefepime—Convulsion—Methotrexate—colon cancer	0.00155	0.00155	CcSEcCtD
Cefepime—Confusional state—Methotrexate—colon cancer	0.00147	0.00147	CcSEcCtD
Cefepime—Anaphylactic shock—Methotrexate—colon cancer	0.00146	0.00146	CcSEcCtD
Cefepime—Infection—Methotrexate—colon cancer	0.00145	0.00145	CcSEcCtD
Cefepime—Hypersensitivity—Capecitabine—colon cancer	0.00145	0.00145	CcSEcCtD
Cefepime—Thrombocytopenia—Methotrexate—colon cancer	0.00143	0.00143	CcSEcCtD
Cefepime—Pruritus—Capecitabine—colon cancer	0.00139	0.00139	CcSEcCtD
Cefepime—Diarrhoea—Capecitabine—colon cancer	0.00134	0.00134	CcSEcCtD
Cefepime—Paraesthesia—Methotrexate—colon cancer	0.00131	0.00131	CcSEcCtD
Cefepime—Dyspnoea—Methotrexate—colon cancer	0.0013	0.0013	CcSEcCtD
Cefepime—Dizziness—Capecitabine—colon cancer	0.0013	0.0013	CcSEcCtD
Cefepime—Gastrointestinal disorder—Methotrexate—colon cancer	0.00126	0.00126	CcSEcCtD
Cefepime—Pain—Methotrexate—colon cancer	0.00125	0.00125	CcSEcCtD
Cefepime—Vomiting—Capecitabine—colon cancer	0.00125	0.00125	CcSEcCtD
Cefepime—Rash—Capecitabine—colon cancer	0.00124	0.00124	CcSEcCtD
Cefepime—Dermatitis—Capecitabine—colon cancer	0.00124	0.00124	CcSEcCtD
Cefepime—Headache—Capecitabine—colon cancer	0.00123	0.00123	CcSEcCtD
Cefepime—Feeling abnormal—Methotrexate—colon cancer	0.00121	0.00121	CcSEcCtD
Cefepime—Gastrointestinal pain—Methotrexate—colon cancer	0.0012	0.0012	CcSEcCtD
Cefepime—Nausea—Capecitabine—colon cancer	0.00117	0.00117	CcSEcCtD
Cefepime—Urticaria—Methotrexate—colon cancer	0.00116	0.00116	CcSEcCtD
Cefepime—Abdominal pain—Methotrexate—colon cancer	0.00116	0.00116	CcSEcCtD
Cefepime—Body temperature increased—Methotrexate—colon cancer	0.00116	0.00116	CcSEcCtD
Cefepime—Hypersensitivity—Methotrexate—colon cancer	0.00108	0.00108	CcSEcCtD
Cefepime—Pruritus—Methotrexate—colon cancer	0.00103	0.00103	CcSEcCtD
Cefepime—Diarrhoea—Methotrexate—colon cancer	0.001	0.001	CcSEcCtD
Cefepime—Dizziness—Methotrexate—colon cancer	0.000967	0.000967	CcSEcCtD
Cefepime—Vomiting—Methotrexate—colon cancer	0.00093	0.00093	CcSEcCtD
Cefepime—Rash—Methotrexate—colon cancer	0.000922	0.000922	CcSEcCtD
Cefepime—Dermatitis—Methotrexate—colon cancer	0.000921	0.000921	CcSEcCtD
Cefepime—Headache—Methotrexate—colon cancer	0.000916	0.000916	CcSEcCtD
Cefepime—Nausea—Methotrexate—colon cancer	0.000869	0.000869	CcSEcCtD
